Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic lupus erythematosus (SLE) today]

V Carisdeo1, S Messina, M L Rolandi

  • 1Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi di Pavia.

Minerva Medica
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-linked Emery-Dreifuss muscular dystrophy: a multicenter, Italian, cohort study.

Journal of neurology·2026
Same author

Long term clinical follow-up and natural history in a cohort of Italian patients with GNE myopathy: the experience of a single centre.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Same author

Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis.

Journal of neurology·2025
Same author

A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review.

Neuromuscular disorders : NMD·2023
Same author

Bone quality in Duchenne muscular dystrophy.

Journal of endocrinological investigation·2022
Same author

The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritis.

Multiple sclerosis journal - experimental, translational and clinical·2022
Same journal

Tumor-induced osteomalacia: a 2026 update.

Minerva medica·2026
Same journal

Smoking, healthy lifestyle and adolescence.

Minerva medica·2026
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
See all related articles

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with varied symptoms and limited known causes. Advances in treatment have significantly improved patient survival and disease-free periods.

Area of Science:

  • Immunology
  • Rheumatology
  • Epidemiology

Context:

  • Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease.
  • Its etiology is multifactorial and not fully understood, with significant immunoregulation disorders.
  • Epidemiological links to origin or race are not established.

Purpose:

  • To describe the complex nature of Systemic Lupus Erythematosus (SLE).
  • To highlight the diagnostic challenges posed by its polymorphous symptomatology.
  • To review the current therapeutic approaches and their impact on prognosis.

Summary:

  • SLE presents with highly variable clinical symptoms, making diagnosis difficult.
  • The disease is characterized by severe disorders in immunoregulation.

Related Experiment Videos

  • Current therapeutic strategies involve combined or sequential treatments.

    • Impact:

    • Recent therapeutic advancements have improved patient prognosis, leading to longer survival.
    • Effective management strategies contribute to prolonged disease-free periods for SLE patients.
    • Improved outcomes signify a brighter future for individuals diagnosed with SLE.